keyword
https://read.qxmd.com/read/38652869/inflammation-and-acinar-cell-dual-targeting-nanomedicines-for-synergistic-treatment-of-acute-pancreatitis-via-ca-2-homeostasis-regulation-and-pancreas-autodigestion-inhibition
#1
JOURNAL ARTICLE
Yanan Wang, Xinyuan Wang, Xue Zhang, Baomei Zhang, Xinlei Meng, Deyao Qian, Yatao Xu, Liangmin Yu, Xuefeng Yan, Zhiyu He
Severe acute pancreatitis (AP) is a life-threatening pancreatic inflammatory disease with a high mortality rate (∼40%). Existing pharmaceutical therapies in development or in clinical trials showed insufficient treatment efficacy due to their single molecular therapeutic target, poor water solubility, short half-life, limited pancreas-targeting specificity, etc. Herein, acid-responsive hollow mesoporous Prussian blue nanoparticles wrapped with neutrophil membranes and surface modified with the N , N -dimethyl-1,3-propanediamine moiety were developed for codelivering membrane-permeable calcium chelator BAPTA-AM (BA) and trypsin activity inhibitor gabexate mesylate (Ga)...
April 23, 2024: ACS Nano
https://read.qxmd.com/read/38652439/cost-effectiveness-of-recombinant-factor%C3%A2-ix-fc-prophylaxis-and-recombinant-factor%C3%A2-ix-on-demand-treatment-in-patients-with-haemophilia%C3%A2-b-without-inhibitors
#2
JOURNAL ARTICLE
Michal Pochopien, Anna Tytuła, Mondher Toumi, Aletta Falk, Nicoletta Martone, Zalmai Hakimi, Daniel Eriksson
INTRODUCTION: Recombinant factor IX (rFIX) and recombinant FIX Fc fusion protein (rFIXFc) are standard half-life and extended half-life FIX replacement therapies, respectively, and represent established treatment options indicated for adults and children with haemophilia B. These FIX replacement therapies can be administered as prophylaxis (to prevent bleeding) or 'on-demand' (to stop bleeding). This analysis aimed to estimate the cost-effectiveness of once-weekly prophylaxis with rFIXFc versus on-demand treatment with rFIX in patients with haemophilia B without inhibitors in the Italian healthcare setting...
April 23, 2024: Advances in Therapy
https://read.qxmd.com/read/38651516/medium-sized-peptides-from-microbial-sources-with-potential-for-antibacterial-drug-development
#3
REVIEW
Jianwei Chen, Wei Wang, Xubin Hu, Yujie Yue, Xingyue Lu, Chenjie Wang, Bin Wei, Huawei Zhang, Hong Wang
Covering: 1993 to the end of 2022As the rapid development of antibiotic resistance shrinks the number of clinically available antibiotics, there is an urgent need for novel options to fill the existing antibiotic pipeline. In recent years, antimicrobial peptides have attracted increased interest due to their impressive broad-spectrum antimicrobial activity and low probability of antibiotic resistance. However, macromolecular antimicrobial peptides of plant and animal origin face obstacles in antibiotic development because of their extremely short elimination half-life and poor chemical stability...
April 23, 2024: Natural Product Reports
https://read.qxmd.com/read/38651193/single-and-multiple-dose-pharmacokinetics-of-gefapixant-mk-7264-a-p2x3-receptor-antagonist-in-healthy-adults
#4
JOURNAL ARTICLE
Jesse C Nussbaum, Azher Hussain, Peter Butera, Anthony P Ford, Michael M Kitt, Edward A O'Neill, Steven Smith, Gabriel Vargas, Terry O'Reilly, Chris Wynne, S Aubrey Stoch, Marian Iwamoto
Gefapixant (MK-7264, RO4926219, AF-219) is a first-in-class P2X3 antagonists being developed to treat refractory or unexplained chronic cough. The initial single- and multiple-dose safety, tolerability, and pharmacokinetics of gefapixant at doses ranging from 7.5 to 1800 mg were assessed in four clinical trials. Following single-dose administration of 10-450 mg, the pharmacokinetic (PK) profile of gefapixant in plasma and urine demonstrated low inter-subject variability and a dose-proportional exposure. Following administration of multiple doses twice daily, the plasma exposures were dose-proportional at doses ranging from 7...
April 23, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38647198/rescuing-a-troubled-tolcapone-with-pegylated-plga-nanoparticles-design-characterization-and-hepatotoxicity-evaluation
#5
JOURNAL ARTICLE
Miguel Pinto, Cláudia Sofia Machado, Sandra Barreiro, Francisco J Otero-Espinar, Fernando Remião, Fernanda Borges, Carlos Fernandes
Tolcapone is an orally active catechol-O-methyltransferase (COMT) inhibitor used as adjuvant therapy in Parkinson's disease. However, it has a highly hepatotoxic profile, as recognized by the U.S. Food and Drug Administration. As a possible solution, nanoscience brought us several tools in the development of new functional nanomaterials with tunable physicochemical properties, which can be part of a solution to solve several drawbacks, including drug's short half-life and toxicity. This work aims to use PEGylated poly(lactic- co -glycolic acid) (PLGA) nanoparticles as a stable carrier with lower hydrodynamic size and polydispersity to encapsulate tolcapone in order to overcome its therapeutic drawbacks...
April 22, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38646838/biotransformation-and-disposition-characteristics-of-hsk7653-a-novel-long-acting-dipeptidyl-peptidase-4-inhibitor-for-the-treatment-of-type-2-diabetes
#6
JOURNAL ARTICLE
Yi-Cong Bian, Jian Meng, Tao Hu, Sheng Ma, Chen-Rong Huang, Feng-Yi Zhang, Qing-He Wu, Hua Zhang, Xiao-Yan Chen, Li-Yan Miao
AIM: To investigate the metabolism and disposition characteristics of HSK7653 in healthy male Chinese participants. METHODS: A single oral dose of 80 μCi (25 mg) [14 C]HSK7653 capsules was administered to six healthy participants, and blood, plasma, urine and faeces were collected. Quantitative and qualitative analysis was conducted to investigate the pharmacokinetics, blood-to-plasma ratio, mass balance and metabolism of HSK7653. RESULTS: The drug was well absorbed and reached a maximum concentration at 1...
April 22, 2024: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/38646595/dextrin-conjugation-to-colistin-inhibits-its-toxicity-cellular-uptake-and-acute-kidney-injury-in-vivo
#7
JOURNAL ARTICLE
Mathieu Varache, Siân Rizzo, Edward J Sayers, Lucy Newbury, Anna Mason, Chia-Te Liao, Emilie Chiron, Nathan Bourdiec, Adam Jones, Donald J Fraser, Philip R Taylor, Arwyn T Jones, David W Thomas, Elaine L Ferguson
The acute kidney injury (AKI) and dose-limiting nephrotoxicity, which occurs in 20-60% of patients following systemic administration of colistin, represents a challenge in the effective treatment of multi-drug resistant Gram-negative infections. To reduce clinical toxicity of colistin and improve targeting to infected/inflamed tissues, we previously developed dextrin-colistin conjugates, whereby colistin is designed to be released by amylase-triggered degradation of dextrin in infected and inflamed tissues, after passive targeting by the enhanced permeability and retention effect...
April 18, 2024: RSC Pharm
https://read.qxmd.com/read/38645886/identification-and-characterisation-of-moderately-thermostable-diisobutyl-phthalate-degrading-esterase-from-a-great-artesian-basin-bacillus-velezensis-np05
#8
JOURNAL ARTICLE
Brandon Mu, Pawel Sadowski, Junior Te'o, Bharat Patel, Nayana Pathiraja, Kevin Dudley
Phthalate esters are known to be endocrine disrupting chemicals and are documented to pollute environments. Enzymatic degradation of PAEs is a potential bioremedial strategy to manage contamination. Thermostable bioremedial enzymes have advantages in enzyme manufacturing and storage. In this study, we identified, overexpressed, and characterised a moderately thermostable para-nitrobenzyl esterase from whole genome sequencing of a Bacillus velezensis NP05 from the Great Artesian Basin , capable of sequential 2-step hydrolysis of diisobutyl phthalate...
June 2024: Biotechnology Reports
https://read.qxmd.com/read/38645297/dalbavancin-as-an-alternative-to-traditional-outpatient-parenteral-antimicrobial-therapy-for-deep-gram-positive-infections-an-observational-retrospective-review
#9
JOURNAL ARTICLE
Hongkai Bao, Rita Igwilo-Alaneme, Fnu Sonia, Kelsie Cowman, Mani Kahn, Priya Nori
BACKGROUND: Treatment of invasive gram-positive infections in complex patient populations is challenging. Dalbavancin, approved for skin and soft tissue infections, offers advantages in this setting due to its long half-life and infrequent dosing. However, less is known about the outcomes of off-label dalbavancin for deeper infections. OBJECTIVES: The objective of this study is to examine the feasibility and outcomes of patients with complex gram-positive infections treated with dalbavancin as an alternative to standard outpatient parenteral antimicrobial therapy (OPAT)...
2024: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38644462/evaluation-of-ornidazole-tablets-bioequivalence-in-chinese-healthy-participants-under-fasted-and-fed-conditions-using-pharmacokinetic-parameters
#10
JOURNAL ARTICLE
Yanrong Wang, Yuanyuan He, Weihong Li, Hongmin Li, Liyuan Tang, Xinya Dai, Yingzi Pei, Lijing Gao
BACKGROUND AND OBJECTIVE: Ornidazole, the third generation of nitroimidazole derivatives after metronidazole and tinidazole, it exerts both bactericidal and antiprotozoal effects. The purpose of this study was to evaluate the pharmacokinetic and bioequivalence of two ornidazole tablets manufactured by two different manufacturers based on their pharmacokinetic parameters. PATIENTS AND METHODS: Fasted and fed healthy Chinese volunteers participated in a randomized sequence, single-dose, open-label, two-period crossover trial...
April 22, 2024: Drugs in R&D
https://read.qxmd.com/read/38644454/efgartigimod-as-a-novel-fcrn-inhibitor-for-autoimmune-disease
#11
REVIEW
Yun Yang, Zhengxuan Shen, Fan Shi, Fei Wang, Ning Wen
Immunoglobulin G (IgG) autoantibodies can lead to the formation of autoimmune diseases through Fab and/or Fc-mediated interactions with host molecules as well as activated T cells. The neonatal Fc receptor (FcRn) binds at acidic pH IgG and albumin, and the mechanism for prolonging serum IgG half-life is making IgG re-entry into circulation by prompting it not to be degraded by lysosomes and back to the cell surface. Given the FcRn receptor's essential role in IgG homeostasis, one of the strategies to promote the quick degradation of endogenous IgG is to suppress the function of FcRn, which is beneficial to the treatment of IgG-driven autoimmune disorders like myasthenia gravis (MG), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), stiff person syndrome, and immune thrombocytopenia (ITP)...
April 22, 2024: Neurological Sciences
https://read.qxmd.com/read/38644425/biodegradation-of-polyethylene-pe-polypropylene-pp-and-polystyrene-ps-microplastics-by-floc-forming-bacteria-bacillus-cereus-strain-shbf2-isolated-from-a-commercial-aquafarm
#12
JOURNAL ARTICLE
Shahadat Hossain, Zuhayra Nasrin Ahmad Shukri, Khor Waiho, Yusof Shuaib Ibrahim, Amyra Suryatie Kamaruzzan, Ahmad Ideris Abdul Rahim, Ahmad Shuhaimi Draman, Wahidah Wahab, Helena Khatoon, Nor Azman Kasan
The ubiquitous proximity of the commonly used microplastic (MP) particles particularly polyethylene (PE), polypropylene (PP), and polystyrene (PS) poses a serious threat to the environment and human health globally. Biological treatment as an environment-friendly approach to counter MP pollution has recent interest when the bio-agent has beneficial functions in their ecosystem. This study aimed to utilize beneficial floc-forming bacteria Bacillus cereus SHBF2 isolated from an aquaculture farm in reducing the MP particles (PE, PP, and PS) from their environment...
April 22, 2024: Environmental Science and Pollution Research International
https://read.qxmd.com/read/38644217/dna-repair-is-efficient-in-irradiated-m-phase-zygotes
#13
JOURNAL ARTICLE
Yuan Wang, Dai Tsukioka, Shoji Oda, Hiroshi Mitani, Fugaku Aoki
In somatic cells, DNA repair is attenuated during mitosis to prevent the formation of anaphase bridges and facilitate the proper segregation of sister chromatids. Irradiation-induced γH2AX foci persist for hours in M phase somatic cells. However, we observed that anaphase bridges formed in a significant fraction of mouse zygotes irradiated during mitosis. Additionally, γH2AX signals in M phase zygotes peaked 30 min after irradiation and subsequently reduced with a half-life within 1-2 h. These results suggest that the DNA repair system may operate efficiently in M phase zygotes following irradiation, leading to the frequent formation of anaphase bridges...
April 19, 2024: Journal of Reproduction and Development
https://read.qxmd.com/read/38643814/a-one-two-punch-strategy-for-diabetic-wound-management-based-on-an-antibiotic-hybrid-biomineralized-iron-sulfide-nanoparticle
#14
JOURNAL ARTICLE
Shuangpiao Deng, Kaixin Ou, Chenyu Zhang, Daojing Yuan, Xiaowen Cai, Fengtan Li, Xuetao Wang, Jing Yin, Chuanshan Xu, Yanli Li, Teng Gong
Bacterial infection and immune imbalance are the primary culprits behind chronic wounds in individuals with diabetes, impeding the progression of damaged tissues towards normal healing. To achieve a harmonious balance between pro- and anti-inflammation within these infected areas, herein, we propose a one-two punch strategy for on-demand therapy of diabetes-infected wounds, utilizing an azithromycin (AZM)-hybrid nanocomposite termed GOx@Fex Sy /AZM. During the infective stage, the nanocomposite facilitates the production of ROS, coupled with the burst release of AZM and H2 S gas, effectively dismantling biofilms and achieving rapid sterilization...
April 19, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38643561/label-free-cell-phenotypic-profiling-of-histamine-h4r-receptor-and-discovery-of-non-competitive-h4r-antagonist-from-natural-products
#15
JOURNAL ARTICLE
Hongming Tang, Tao Hou, Han Zhou, Han Liao, Fangfang Xu, Xiaomin Xie, Wenjie Yuan, Zhixin Guo, Yanfang Liu, Jixia Wang, Weijia Zhou, Xinmiao Liang
Histamine 4 receptor (H4R), the most recently identified subtype of histamine receptor, primarily induces inflammatory reactions upon activation. Several H4R antagonists have been developed for the treatment of inflammatory bowel disease (IBD) and atopic dermatitis (AD), but their use has been limited by adverse side effects, such as a short half-life and toxicity. Natural products, as an important source of anti-inflammatory agents, offer minimal side effects and reduced toxicity. This work aimed to identify novel H4R antagonists from natural products...
April 18, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38643185/pharmacokinetic-pharmacodynamic-evaluation-of-gamithromycin-against-rabbit-pasteurellosis
#16
JOURNAL ARTICLE
Xin-Yi Wei, Jing Zhang, Yin Zhang, Wen-Zhen Fu, Long-Gen Zhong, Yi-Duo Pan, Jian Sun, Xiao-Ping Liao, Ya-Hong Liu, Yu-Feng Zhou
BACKGROUND: Gamithromycin is an effective therapy for bovine and swine respiratory diseases but not utilized for rabbits. Given its potent activity against respiratory pathogens, we sought to determine the pharmacokinetic profiles, antimicrobial activity and target pharmacokinetic/pharmacodynamic (PK/PD) exposures associated with therapeutic effect of gamithromycin against Pasteurella multocida in rabbits. RESULTS: Gamithromycin showed favorable PK properties in rabbits, including high subcutaneous bioavailability (86...
April 20, 2024: BMC Veterinary Research
https://read.qxmd.com/read/38642503/conjugation-of-sulpiride-with-a-cell-penetrating-peptide-to-augment-the-antidepressant-efficacy-and-reduce-serum-prolactin-levels
#17
JOURNAL ARTICLE
Yuan Liang, Yu Yang, Ruiyan Huang, Jiangyue Ning, Xingyan Bao, Zelong Yan, Haotian Chen, Li Ding, Chang Shu
Depression ranks as the fourth most prevalent global disease, with suicide incidents occurring at a younger age. Sulpiride (SUL), an atypical antidepressant drug acting as a dopamine D2 receptor antagonist and possessing anti-inflammatory properties, exhibits limited ability to penetrate the blood brain barrier (BBB). This weak penetration hampers its inhibitory effect on prolactin release in the pituitary gland, consequently leading to hyperprolactinemia. In order to enhance the central nervous system efficacy of sulpiride and reduce serum prolactin levels, we covalently linked sulpiride to VPALR derived from the nuclear DNA repair protein ku70...
April 19, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38641146/effective-skin-decontamination-with-rsdl%C3%A2-reactive-skin-decontamination-lotion-kit-following-dermal-exposure-to-a-novichok-class-nerve-agent
#18
JOURNAL ARTICLE
Alex S Cornelissen, Roland M van den Berg, Jan P Langenberg, Marco van Grol, Rowdy Bross, John Pittman, Laura Cochrane, Vladimir Savransky
In recent years, various poisoning incidents have been reported, involving the alleged use of the so-called Novichok agents, resulting in their addition to the Schedule I list of the Organisation for the Prohibition of Chemical Warfare (OPCW). As the physicochemical properties of these agents are different from the 'classical' nerve agents, such as VX, research is needed to evaluate whether and to what extent existing countermeasures are effective. Here, we evaluated the therapeutic potential of RSDL® (Reactive Skin Decontamination Lotion Kit) for the neutralization of percutaneous toxicity caused by Novichok agents, both in vitro and in vivo...
April 17, 2024: Chemico-biological Interactions
https://read.qxmd.com/read/38640868/identification-of-ch-2-linked-quinolone-aminopyrimidine-hybrids-as-potent-anti-mrsa-agents-low-resistance-potential-and-lack-of-cross-resistance-with-fluoroquinolone-antibiotics
#19
JOURNAL ARTICLE
Hongxue Dai, Yue Hu, Yiwen Zhang, Qi Zhu, Tao Xu, Peng Cui, Renhua Fan, Qiuqin He
The structural optimization of B14, an antibacterial agent we previously obtained, has led to the discovery of a new class of CH2 -linked quinolone-aminopyrimidine hybrids with potent anti-MRSA activities. Surprisingly, the hybrids lacking a C-6 fluoro atom at the quinolone nucleus showed equal or even stronger anti-MRSA activities than their corresponding 6-fluoro counterparts, despite the well-established structure-activity relationships (SARs) indicating that the 6-fluoro substituent enhances the antibacterial activity in conventional fluoroquinolone antibiotics...
April 11, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38639108/quantitative-assessment-of-drug-efficacy-and-emergence-of-resistance-in-patients-with-metastatic-renal-cell-carcinoma-using-a-longitudinal-exposure-tumor-growth-inhibition-model-apitolisib-dual-pi3k-mtorc1-2-inhibitor-versus-everolimus-mtorc1-inhibitor
#20
JOURNAL ARTICLE
Anita Moein, Jin Y Jin, Matthew R Wright, Harvey Wong
Cancer remains a significant global health challenge, and despite remarkable advancements in therapeutic strategies, poor tolerability of drugs (causing dose reduction/interruptions) and/or the emergence of drug resistance are major obstacles to successful treatment outcomes. Metastatic renal cell carcinoma (mRCC) accounts for 2% of global cancer diagnoses and deaths. Despite the initial success of targeted therapies in mRCC, challenges remain to overcome drug resistance that limits the long-term efficacy of these treatments...
April 19, 2024: Journal of Clinical Pharmacology
keyword
keyword
91311
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.